HDSN trades 53.1% below Wall Street's consensus target of $9.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HDSN achieves its forward estimates and maintains a stable P/E multiple of 15.5x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Hudson Technologies, Inc. (HDSN) has a Wall Street consensus price target of $9.00, based on estimates from 8 covering analysts. With the stock currently trading at $5.88, this represents a potential upside of +53.1%. The company has a market capitalization of $250M.
Analyst price targets range from a low of $9.00 to a high of $9.00, representing a 0% spread in expectations. The median target of $9.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, HDSN trades at a trailing P/E of 15.9x and forward P/E of 15.5x. Analysts expect EPS to grow +13.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $10.99, with bear and bull scenarios of $6.92 and $14.47 respectively. Model confidence stands at 39/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AIRGAirgain, Inc. | $83M | $6.78 | — | — | — | — | — |
CLNEClean Energy Fuels Corp. | $410M | $1.86 | $3.50 | +88.2% | Buy | — | 22 |
APDAir Products and Chemicals, Inc. | $62.4B | $280.21 | $325.63 | +16.2% | Buy | 21.2x | 42 |
LINLinde plc | $237.3B | $512.15 | $562.14 | +9.8% | Buy | 28.6x | 28 |
ASXASE Technology Holding Co., Ltd. | $88.7B | $40.56 | — | — | Buy | 1.2x | 5 |
WLKPWestlake Chemical Partners LP | $797M | $22.60 | $29.00 | +28.3% | Hold | 12.0x | 10 |
CCThe Chemours Company | $3.3B | $21.77 | $25.75 | +18.3% | Hold | 15.5x | 20 |
HONHoneywell International Inc. | $145.1B | $229.01 | $249.64 | +9.0% | Buy | 21.8x | 28 |
MMM3M Company | $83.8B | $160.60 | $166.75 | +3.8% | Hold | 18.5x | 33 |
CARRCarrier Global Corporation | $60.0B | $71.81 | $68.86 | -4.1% | Buy | 25.6x | 26 |
Quick answers to the most common questions about buying HDSN stock.
The consensus Wall Street price target for HDSN is $9, representing 53.1% upside from the current price of $5.88. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HDSN has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $9 implies 53.1% upside from current levels.
With a forward P/E of 15.4737x, HDSN trades at a relatively low valuation. The consensus target of $9 implies 53.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $9 for HDSN, while the most conservative target is $9. The consensus of $9 represents the median expectation. Our quantitative valuation model projects a bull case target of $14 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HDSN is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HDSN stock forecast based on 8 Wall Street analysts shows a consensus price target of $9, with estimates ranging from $9 (bear case) to $9 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $11, with bear/bull scenarios of $7/$14.
Our quantitative valuation model calculates HDSN's fair value at $11 (base case), with a bear case of $7 and bull case of $14. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 39/100.
HDSN trades at a forward P/E ratio of 15.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 15.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HDSN, with a "Hold" consensus rating and $9 price target (53.1% upside). 3 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HDSN analyst price targets range from $9 to $9, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $9 consensus represents the middle ground. Our model's $7-$14 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.